Product image of Cyramza (Ramucirumab) supplied by GNH India

Cyramza

Active Ingredient:
Ramucirumab
Origin:
EU

Cyramza (Ramucirumab)

Cyramza (Ramucirumab) is an intravenous medication used to treat certain types of cancer. This targeted therapy is designed to inhibit angiogenesis, the process of forming new blood vessels.

Manufacturer / TM Owner

Eli Lilly Nederland B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Cyramza is primarily used in combination with other cancer treatments for advanced or metastatic cancers. It is often prescribed for gastric or gastro-esophageal junction adenocarcinoma, non-small cell lung cancer, and colorectal cancer. Patients may wonder, 'What is Cyramza used for?' It is typically used to slow the progression of these cancers when they have spread to other parts of the body.

Side Effects

  • Common effects of Cyramza may include fatigue, hypertension, and diarrhea. Some patients may experience appetite loss or nausea. These effects can vary widely among individuals and are not exhaustive. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

  • Cyramza should be administered under medical supervision due to its potent nature. Patients with a history of severe hypertension or bleeding disorders should discuss their medical history with their healthcare provider. Proper monitoring is essential during treatment.

Avoid Interactions

  • Cyramza may interact with other medications, particularly those that affect blood pressure or blood clotting. Alcohol and certain over-the-counter drugs may also influence its effects. Always inform your healthcare provider about all medications you are taking.

Frequently Asked Questions

Cyramza is used in combination with other treatments for certain types of advanced or metastatic cancers, such as gastric cancer and non-small cell lung cancer.

Cyramza is administered intravenously by a healthcare professional in a clinical setting.

Common side effects may include fatigue, hypertension, and diarrhea. Always consult a healthcare provider for personalized advice.

Cyramza is typically used in combination with other cancer treatments and is not usually prescribed as a standalone therapy.

Patients with a history of severe hypertension or bleeding disorders should discuss their medical history with their healthcare provider before starting Cyramza.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ramucirumab

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT